Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Revenue

Ionis Pharmaceuticals had revenue of $452.05M in the quarter ending June 30, 2025, with 100.69% growth. This brings the company's revenue in the last twelve months to $944.05M, up 16.05% year-over-year. In the year 2024, Ionis Pharmaceuticals had annual revenue of $705.14M, down -10.48%.

• Revenue (ttm): $944.05M
• Revenue Growth: +16.05%
• P/S Ratio: 11.57
• Revenue / Employee: $883,115
• Employees: 1,069
• Market Cap: 11.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	705.14M	-82.51M	-10.48%
Dec 31, 2023	787.65M	200.28M	34.10%
Dec 31, 2022	587.37M	-223.09M	-27.53%
Dec 31, 2021	810.46M	81.19M	11.13%
Dec 31, 2020	729.26M	376.81M	106.91%
Dec 31, 2019	352.45M	97.53M	38.26%
Dec 31, 2018	254.92M	134.91M	112.41%
Dec 31, 2017	120.01M	97.25M	427.14%
Dec 31, 2016	22.77M	20.42M	871.70%
Dec 31, 2015	2.34M	-211.82M	-98.91%
Dec 31, 2014	214.16M	66.88M	45.41%
Dec 31, 2013	147.29M	45.24M	44.33%
Dec 31, 2012	102.05M	2.96M	2.99%
Dec 31, 2011	99.09M	-9.39M	-8.65%
Dec 31, 2010	108.47M	-13.13M	-10.80%
Dec 31, 2009	121.60M	14.41M	13.44%
Dec 31, 2008	107.19M	48.85M	83.72%
Dec 31, 2007	58.34M	43.49M	292.65%
Dec 31, 2006	14.86M	-13.48M	-47.57%
Dec 31, 2005	28.34M	-	-